Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Witty Tyagi
Institution:
National Institute of Immunology
Observed institution:
National Institute of Immunology
ORCID:
0000-0002-6164-3523
Observed ORCID:
0000-0002-6164-3523
OpenAlex ID:
A5059640550
Tumor Antigen-Primed Dendritic Cell-Derived Exosome Synergizes with Colony Stimulating Factor-1 Receptor Inhibitor by Modulating the Tumor Microenvironment and Systemic Immunity
2023
·
Anjali Barnwal
, Vidit Gaur
, et al.
·
ACS Biomaterials Science & Engineering
·
28
Membrane linked RNA glycosylation as new trend to envision epi-transcriptome epoch
2022
·
Witty Tyagi
, Vivek Pandey
, et al.
·
Cancer Gene Therapy
·
25
Temporal regulation of acetylation status determines PARP1 role in DNA damage response and metabolic homeostasis
2024
·
Witty Tyagi
, Sanjeev Das
·
Science Advances
·
13
CD40 agonist engineered immunosomes modulated tumor microenvironment and showed pro-immunogenic response, reduced toxicity, and tumor free survival in mice bearing glioblastoma
2024
·
Vidit Gaur
, Witty Tyagi
, et al.
·
Biomaterials
·
10
HDAC5 modulates SATB1 transcriptional activity to promote lung adenocarcinoma
2023
·
Shalakha Sharma
, Witty Tyagi
, et al.
·
British Journal of Cancer
·
10
PDF
Carboxyl nanodiamonds inhibit melanoma tumor metastases by blocking cellular motility and invasiveness
2023
·
Sushreesangita P Behera
, Witty Tyagi
, et al.
·
PNAS Nexus
·
1
PDF
Ponatinib Averts αCD40 Antibody Mediated Toxicity by Lowering MAPK38 Expression and Shows Proimmunogenic Effects in a Murine Tumor Model
2025
·
Vidit Gaur
, Anjali Barnwal
, et al.
·
ACS Pharmacology & Translational Science
Abstract 5312: Agonist CD40 engineered smart immunosomes induced anti-tumor immunity, reduced associated toxicities and showed tumor free survival in murine glioblastoma model
2024
·
Vidit Gaur
, Witty Tyagi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
87
H-index:
5
I10-index:
5
Year
Topic
Type